Teva Pharmaceutical (Israel) Investor Sentiment

TEVA Stock  ILA 5,309  301.00  5.37%   
About 61% of Teva Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Teva Pharmaceutical Industries suggests that many traders are alarmed regarding Teva Pharmaceutical's prospects. The current market sentiment, together with Teva Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use Teva Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
  
over a year ago at news.google.com         
Teva Pharmaceutical Industries Enters Oversold Territory - Nasdaq
Google News at Macroaxis
over a year ago at news.google.com         
Teva to Provide Second Round of Funding to Clinics in California ... - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Pediatric Vaccines Market Size Ascends Estimated USD 98.8 Billion ... - GlobeNewswire
Google News at Macroaxis
over a year ago at news.google.com         
Assenagon Asset Management Shows Confidence in Teva ... - Best Stocks
Google News at Macroaxis
over a year ago at news.google.com         
Spartan Fund Management Inc. Decreases Stock Holdings in Teva ... - MarketBeat
Google News at Macroaxis
over a year ago at news.google.com         
Teva Pharmaceutical Industries Now Covered by ... - MarketBeat
Google News at Macroaxis
over a year ago at news.google.com         
Anticonvulsant Drugs Market Overall Study Report 2023-2030 ... - Digital Journal
Google News at Macroaxis
over a year ago at news.google.com         
Sanofi partners with Janssen, Teva on E. coli, IBD treatments - NJBIZ
Google News at Macroaxis
over a year ago at news.google.com         
Significant Reduction in Harel Insurances Position in Teva ... - Best Stocks
Google News at Macroaxis
over a year ago at news.google.com         
Pyrazinamide Market 2023-2030 Growth Rate, Manufacturers ... - Digital Journal
Google News at Macroaxis
over a year ago at news.google.com         
Significant Block Trade in IFUS Highlights Importance of Investment ... - Best Stocks
Google News at Macroaxis
over a year ago at news.google.com         
Analyst Upgrades Teva Pharmaceuticals Price Target to 11 - Best Stocks
Google News at Macroaxis
over a year ago at news.google.com         
Duality Advisers LP Makes New 2.61 Million Investment in Teva ... - MarketBeat
Google News at Macroaxis
over a year ago at news.google.com         
Ghisallo Capital Management LLC Purchases New Shares in Teva ... - MarketBeat
Google News at Macroaxis
over a year ago at news.google.com         
Global Active Pharmaceutical Ingredient API Market Assessment 2023-2031 Industry Size, Share and Top...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Teva Pharmaceutical that are available to investors today. That information is available publicly through Teva media outlets and privately through word of mouth or via Teva internal channels. However, regardless of the origin, that massive amount of Teva data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Teva Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Teva Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Teva Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Teva Pharmaceutical alpha.

Teva Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Teva Stock analysis

When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Stocks Directory
Find actively traded stocks across global markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges